DentalMonitoring Secures $100M to Scale AI Remote Orthodontic Monitoring Worldwide

DentalMonitoring Secures $100M To Scale AI Remote Orthodontic Monitoring - What Product Teams Should Track

DentalMonitoring raised a combined $100 million led by Lazard Elaia Capital with participation from ISALT (Fonds Stratégique des Transitions). The company hit operational profitability in 2025 and is using the raise to speed up international growth and AI-driven product development. For product leaders, this is a signal: orthodontics is moving from siloed tools to a connected operating layer for digital dental care.

The product thesis: platform-first, treatment-agnostic

DentalMonitoring builds software-as-a-medical-device for remote orthodontic supervision. The platform is treatment and appliance-agnostic, now used by 2+ million patients and tightly integrated with manufacturers and industry platforms. That points to an API-first approach, partner-led distribution, and workflow-native UX that fits into existing clinic systems rather than replacing them.

Why this matters for product development

• Data advantage at scale: Two billion images feed model training and QA pipelines. Expect higher model generalization across appliance types, device cameras, and real-world lighting conditions.
• Regulatory maturity: FDA De Novo and MDR compliance reduce buyer risk and set a higher bar for competitors. See FDA De Novo guidance here and EU MDR background here.
• Interoperability as a growth lever: Deeper integrations with appliance makers, practice management software, and intraoral scanners increase switching costs and create distribution loops.
• Global product operations: Expansion across Europe, the U.S., Australia, Japan, and new regions (Brazil, Turkey, Southeast Asia, Middle East) means localization, data residency, and clinic onboarding have to be productized.

Roadmap signals to infer

• Beyond orthodontics: The company plans to apply its AI and proprietary data to additional dental uses. Expect new indication frameworks, measurement features, and labeling standards that reuse core infrastructure.
• Workflow automation: More rules engines for clinic triage, notifications, and appointment triggers. Think configurable guardrails for medical review, with clear escalation paths.
• Developer surface area: More partner integrations usually mean SDKs, sandbox environments, and reference implementations to speed OEM and software partners.
• Trust and safety at scale: Continuous post-market surveillance, drift monitoring, and human-in-the-loop review baked into the product.

Go-to-market implications

Geographic expansion plus OEM partnerships suggests a hub-and-spoke model: win manufacturers and platforms, then standardize clinic workflows through embedded monitoring. Pricing likely leans enterprise with volume tiers, SLA-backed support, and compliance documentation packaged as a sales asset. Expect region-specific deployment options and clinic enablement kits for fast rollout.

Technical and regulatory moat

• Data and IP: A two-billion-image library and 470+ patents form a defensible base for model performance and feature velocity.
• Clinical validation: De Novo sets a clear baseline for intended use and risk controls; MDR certification adds credibility in Europe. Together, they compress sales cycles in regulated markets.
• Device heterogeneity: Support for a wide range of phones, scanners, and appliances is a quiet differentiator-less friction means higher patient adherence and better datasets.

What to watch next

• New integrations with major OEMs, scanners, and practice software-and whether APIs/SDKs become publicly documented.
• Feature launches that extend beyond orthodontics into broader dental workflows.
• Localization depth: languages, clinical protocols by region, and data residency options.
• Evidence releases: peer-reviewed studies, real-world performance metrics, and post-market updates that strengthen buyer confidence.

Markets and expansion plan

DentalMonitoring will reinforce its footprint in Europe, the U.S., Australia, and Japan, while moving into Brazil, Turkey, Southeast Asia, and the Middle East. The company also launched a software development center to push AI R&D, signaling faster iteration and feature delivery.

Key quotes

Philippe Salah, Chief Executive Officer, DentalMonitoring: "Lazard Elaia Capital brings both capitals, a strong network, and strategic expertise in building category-leading health tech companies, which make them an ideal partner for our next chapter. Our goal is to bring a new standard of care in orthodontics, leveraging AI to enable efficient clinical supervision outside of practice. We have made major inroads in integrating into the ecosystem, as illustrated by the important partnerships with several manufacturers announced last year. We look forward to continuing that journey, for the benefit of the entire ecosystem, as well as expanding our leading position in the orthodontic remote monitoring market and beyond."

Alexandre Margoline, Managing Partner, Lazard Elaia Capital: "We back companies that build categories, not features. DentalMonitoring's team is creating an operating system for modern dental care. As a company we've been following for many years, we have been impressed to see it grow into an established global leader. Their AI remote monitoring platform scales globally with a treatment and appliance-agnostic model that works with every clinic and every OEM. This combination creates real defensibility and growth opportunities. This is how category leaders are built and why we believe Philippe and his team are leading the way in dental care digitization."

For product teams building AI in healthcare

If you're leveling up skills for regulated AI products and partnerships, explore curated learning paths by job role at Complete AI Training.